Abstract

Atezolizumab and bevacizumab for hepatocellular carcinoma: how to approach salvage therapy for non-responders?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Survival Benefit of Transplantation for Recurrence of Hepatocellular Carcinoma After Liver Resection
G Zanus ... M Polacco
Transplantation Proceedings | VOL. 46
G Zanus, et. al.G Zanus ... M Polacco
01 Sep 2014
Long term nucleotide and nucleoside analogs treatment in chronic hepatitis B HBeAg negative genotype D patients and risk for hepatocellular carcinoma
... Massimo Marignani
Annals of Hepatology | VOL. 13
, et. al. ... Massimo Marignani
01 Jul 2014
Salvage Surgery Following Downstaging of Unresectable Hepatocellular Carcinoma—A Strategy to Increase Resectability
Wan Yee Lau ... Eric C H Lai
Annals of Surgical Oncology | VOL. 14
Wan Yee Lau, et. al.Wan Yee Lau ... Eric C H Lai
22 Sep 2007
Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients.
Wenwen Zhang ... Lantian Tian
Frontiers in oncology | VOL. 11
Wenwen Zhang, et. al.Wenwen Zhang ... Lantian Tian
19 Oct 2021
View more papers

More From: Clinical and molecular hepatology

Paper Title
Journal
Date
Author
Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction.
Mehrangiz Dezhbord ... Kyun-Hwan Kim
Clinical and molecular hepatology | VOL. -
Mehrangiz Dezhbord, et. al.Mehrangiz Dezhbord ... Kyun-Hwan Kim
14 May 2024
Core protein inhibitors: Opportunities and challenges at the forefront of hepatitis B cure.
Hae Lim Lee ... Jeong Won Jang
Clinical and molecular hepatology | VOL. -
Hae Lim Lee, et. al.Hae Lim Lee ... Jeong Won Jang
14 May 2024
Unveiling Etiology-Specific Blood Biomarkers in Hepatocellular Carcinoma: A Gateway to Personalized Medicine.
Joseph C Ahn ... Ju Dong Yang
Clinical and molecular hepatology | VOL. -
Joseph C Ahn, et. al.Joseph C Ahn ... Ju Dong Yang
14 May 2024
Macrophage ATG16L1 expression suppresses MASH progression by promoting lipophagy.
Qi Wang ... Ling Lu
Clinical and molecular hepatology | VOL. -
Qi Wang, et. al.Qi Wang ... Ling Lu
10 May 2024
View more papers